GB8821507D0 - Improvements relating to peptides - Google Patents

Improvements relating to peptides

Info

Publication number
GB8821507D0
GB8821507D0 GB888821507A GB8821507A GB8821507D0 GB 8821507 D0 GB8821507 D0 GB 8821507D0 GB 888821507 A GB888821507 A GB 888821507A GB 8821507 A GB8821507 A GB 8821507A GB 8821507 D0 GB8821507 D0 GB 8821507D0
Authority
GB
United Kingdom
Prior art keywords
peptides
improvements relating
relating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB888821507A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Campaign Technology Ltd
Original Assignee
Cancer Research Campaign Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Research Campaign Technology Ltd filed Critical Cancer Research Campaign Technology Ltd
Priority to GB888821507A priority Critical patent/GB8821507D0/en
Publication of GB8821507D0 publication Critical patent/GB8821507D0/en
Priority to PCT/GB1989/001084 priority patent/WO1990002759A1/en
Pending legal-status Critical Current

Links

GB888821507A 1988-09-14 1988-09-14 Improvements relating to peptides Pending GB8821507D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB888821507A GB8821507D0 (en) 1988-09-14 1988-09-14 Improvements relating to peptides
PCT/GB1989/001084 WO1990002759A1 (en) 1988-09-14 1989-09-14 Improvements relating to peptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888821507A GB8821507D0 (en) 1988-09-14 1988-09-14 Improvements relating to peptides

Publications (1)

Publication Number Publication Date
GB8821507D0 true GB8821507D0 (en) 1988-10-12

Family

ID=10643541

Family Applications (1)

Application Number Title Priority Date Filing Date
GB888821507A Pending GB8821507D0 (en) 1988-09-14 1988-09-14 Improvements relating to peptides

Country Status (2)

Country Link
GB (1) GB8821507D0 (en)
WO (1) WO1990002759A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994020859A1 (en) * 1993-03-11 1994-09-15 Laboratoire L. Lafon Kit for diagnosing an hcg- or hcg fragment-secreting cancer and immunotherapeutical means therefor
FR2702494B1 (en) * 1993-03-11 1995-06-09 Lafon Labor Diagnostic kit for cancer secreting hCG or fragments of hCG and vaccine intended for immunotherapy of such cancer.
US5716853A (en) * 1995-07-07 1998-02-10 Chiron Diagnostics Corporation Prenatal down syndrome screening with assays specific for UGP
US6025149A (en) * 1995-07-07 2000-02-15 Yale University Urinary screening for down syndrome and other aneuploidies
US6319504B1 (en) 1996-06-24 2001-11-20 University Of Maryland Biotechnology Institute Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
US5968513A (en) * 1996-06-24 1999-10-19 University Of Maryland Biotechnology Institute Method of promoting hematopoiesis using derivatives of human chorionic gonadotropin
US5997871A (en) * 1996-06-24 1999-12-07 University Of Maryland Biotechnology Insitute Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin
US6583109B1 (en) 1997-06-24 2003-06-24 Robert C. Gallo Therapeutic polypeptides from β-hCG and derivatives
US7994278B1 (en) 1999-08-06 2011-08-09 Nobel Biosciences Llc Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
DE10056136A1 (en) * 2000-11-07 2002-05-16 Nemod New Modalities Inhibiting leukocyte or tumor cell adhesion to vascular endothelial cells e.g. for combating inflammation or metastasis, using e.g. pregnancy proteins or selectin binding liposomes containing calcium-binding compound
KR102079738B1 (en) * 2019-07-04 2020-02-20 에이디텍 주식회사 Novel pregnancy test devices comprising beta core fragment hCG as diagnostic marker

Also Published As

Publication number Publication date
WO1990002759A1 (en) 1990-03-22

Similar Documents

Publication Publication Date Title
ZA895137B (en) Novel peptides
GB8821507D0 (en) Improvements relating to peptides
ZA878336B (en) Peptides
ZA892269B (en) Peptides
GB8821077D0 (en) Peptides
ZA899167B (en) Peptides
GB8828098D0 (en) Peptides
ZA873796B (en) Peptides
ZA878945B (en) Peptides
GB8816222D0 (en) Improvements relating to haridressing
GB8806254D0 (en) Improvements relating to photo-coagulation
GB8821076D0 (en) Peptides
IE882649L (en) Peptides
IE882173L (en) Peptides
IE881990L (en) Peptides
IE881270L (en) Peptides
IE880939L (en) Peptides
GB8804687D0 (en) Peptides
IE881982L (en) Peptides
GB8828404D0 (en) Improvements relating to actinomycins
GB8815324D0 (en) Improvements relating to clips
IE862025L (en) Peptides analogous to grf
IE863014L (en) Peptides
IE860629L (en) Peptides
IE860362L (en) Peptides